Search Result

Results for "

carbamoyl

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adrenergic Receptor (2) Amino Acid Derivatives (1) Antibiotic (1) Biochemical Assay Reagents (1) Dipeptidyl Peptidase (1) Endogenous Metabolite (2) Fungal (1) Isotope-Labeled Compounds (10) Liposome (2) Melanocortin Receptor (2) NOD-like Receptor (NLR) (2) Potassium Channel (1) PROTAC Linkers (1) Radionuclide-Drug Conjugates (RDCs) (5) Somatostatin Receptor (6) Vasopressin Receptor (2)
By Research Areas:	Cancer (12) Cardiovascular Disease (1) Infection (2) Inflammation/Immunology (3) Metabolic Disease (2) Neurological Disease (3)
Click Chemistry:	PROTAC Synthesis (1) Azide (1)
Oligonucleotides:	Cationic Lipids (1) Cholesterol (1)

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Click Chemistry

Oligonucleotides

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-160610A

Carbamoyl phosphate dilithium salt	Others	Others
Carbamoyl phosphate dilithium salt is an antisickling agent and plays a significant role in the urea cycle. Carbamoyl phosphate dilithium salt carbamylates the amino-terminal valine residues of hemoglobin S in erythrocytes, which interferes with the sickling phenomenon. Carbamoyl phosphate dilithium salt exhibits toxicity due to the lithium cation .

HY-128425A

*N-Carbamoyl-L-aspartic acid* L-Ureidosuccinic acid	Endogenous Metabolite	Others
N-Carbamoyl-L-aspartic acid is intermediate of pyrimidine (HY-Y0519) metabolism. N-Carbamoyl-L-aspartic acid can be used to measure enzyme activity of dihydroorotase (DHOse) .

HY-128425

*N-Carbamoyl-DL-aspartic acid* Ureidosuccinic Acid	Endogenous Metabolite	Metabolic Disease
N-Carbamoyl-DL-aspartic acid (Ureidosuccinic acid) is a precursor of nucleic acid pyrimidines .

HY-79680

*(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid*	Amino Acid Derivatives	Others
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid is a phenylalanine derivative .

HY-W705503

*3-Carbamoyl-1-methylpyridin-1-ium-d3 iodide*	Isotope-Labeled Compounds	Others
3-Carbamoyl-1-methylpyridin-1-ium-d₃ (iodide) is deuterium-labeled 3-Carbamoyl-1-methylpyridin-1-ium .

HY-Z3637

*(–)-Sitagliptin carbamoyl* glucuronide**	Dipeptidyl Peptidase	Metabolic Disease
(–)-Sitagliptin carbamoyl glucuronide is a minor metabolite of the dipeptidyl peptidase 4 (DPP-4) inhibitor Sitagliptin (HY-13749).

HY-165695S

*2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-15N2*	Isotope-Labeled Compounds	Others
2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)- ¹⁵N₂ is ¹⁵N labeled 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium) .

HY-146716S

*N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 dicyclohexylamine*	Isotope-Labeled Compounds	Others
N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d₃ (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine.

HY-165694S

*2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2*	Isotope-Labeled Compounds	Others
2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)- ¹³C₂, ¹⁵N₂ is ¹³C and ¹⁵N labeled 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium) .

HY-165704S

*2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium)-d4*	Isotope-Labeled Compounds	Others
2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium)-d₄ is deuterium labeled 2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium) .

HY-140459

*2-((Azido-PEG8-carbamoyl)methoxy)acetic acid*	PROTAC Linkers	Cancer
2-((Azido-PEG8-carbamoyl)methoxy)acetic acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . 2-((Azido-PEG8-carbamoyl)methoxy)acetic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

HY-149664

*3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol* DC-Chol	Liposome	Cancer
3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol, a lipid, has been investigated in cancer gene therapy and vaccine delivery system .

HY-136128

H3B-120	Potassium Channel	Cancer
H3B-120 is a highly selective, competitive and allosteric carbamoyl phosphate synthetase 1 (CPS1) inhibitor with an IC₅₀ of 1.5 μM and a K_i of 1.4 μM. H3B-120 has anti-cancer activity .

HY-P5126

DOTA-LM3 1 Publications Verification	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-LM3 is a somatostatin receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 is often isotopically labeled for tracing tumors in vivo, such as 177Lu-DOTA-LM3 and 68 Ga-DOTA-LM3. 68 Ga-DOTA-LM3 shows favorable biodistribution, high tumor uptake, good tumor retention, and few safety concerns. 177Lu-DOTA-LM3 can be used for research in DOTATOC-negative liver metastases, such as pancreatic NET and extensive tumor thrombosis .

HY-P5126A

DOTA-LM3 TFA 1 Publications Verification	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 TFA is often isotopically labeled for tracing tumors in vivo, such as 177Lu-DOTA-LM3 TFA and 68 Ga-DOTA-LM3 TFA. 68 Ga-DOTA-LM3 TFA shows favorable biodistribution, high tumor uptake, good tumor retention, and few safety concerns. 177Lu-DOTA-LM3 TFA can be used for research in DOTATOC-negative liver metastases, such as pancreatic NET and extensive tumor thrombosis .

HY-49395A

*(S)-4-(4-((4-(4-((2,6-Dioxopiperidin-3-yl)carbamoyl)-3-fluorophenyl)piperazin-1-yl)methyl)piperidin-1-yl)benzoic acid hydrochloride*	Biochemical Assay Reagents	Others
(S)-4-(4-((4-(4-((2,6-Dioxopiperidin-3-yl)carbamoyl)-3-fluorophenyl)piperazin-1-yl)methyl)piperidin-1-yl)benzoic acid hydrochloride is a biological molecule.

HY-P5362

NODAGA-LM3	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
NODAGA-LM3 can be labeled by ⁶⁸Ga for PET imaging. ⁶⁸Ga-NODAGA-LM3 is a SSTR2 antagonist, and can be used for imaging of SSTR positive paragangliomas .

HY-P5362A

NODAGA-LM3 TFA	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
NODAGA-LM3 TFA can be labeled by ⁶⁸Ga for PET imaging. ⁶⁸Ga-NODAGA-LM3 TFA is a SSTR2 antagonist, and can be used for imaging of SSTR positive paragangliomas .

HY-W009512S1

N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d6 N-[(2-chlorophenyl)carbamoyl]phenylalanine-d₆	Isotope-Labeled Compounds	Others
N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d₆ (N-[(2-chlorophenyl)carbamoyl]phenylalanine-d₆) is deuterium-labeled CVT-2738 (HY-W009512) .

HY-W009418S

1-Methylnicotinamide-13C,d3 iodide	Isotope-Labeled Compounds	Others
1-Methylnicotinamide- ¹³C,d₃ (iodide) is the ¹³C- and deuterium labeled 3-Carbamoyl-1-methylpyridin-1-ium iodide[1].

HY-P10137

Satoreotide JR11	Somatostatin Receptor	Cancer
Satoreotide (JR11) is a SSTR2 antagonist. Satoreotide is usually conjugated with radiolabeled chelators used in neuroendocrine tumor imaing .

HY-P5128

DOTA-JR11 Satoreotide tetraxetan	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-JR11 is a somatostatin receptor 2 （SSTR2）antagonist. DOTA-JR11 can be labeled by 68Ga, used for paired imaging in neuroendocrine tumors (NETs) research .

HY-B0711

Carglumic Acid 1 Publications Verification N-Carbamyl-L-glutamic acid	Others	Cancer
Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.

HY-125734

DMHAPC-Chol	Liposome	Others
DMHAPC-Chol, a cationic lipid, contains a biodegradable carbamoyl linker and a hydroxyethyl group in the polar amino head moiety. DMHAPC-Chol can be used in both transfection experiments concerning plasmids or siRNA .

HY-113416AS

Dehydroepiandrosterone sulfate-d6 sodium dihydrate	Isotope-Labeled Compounds	Others
Dehydroepiandrosterone sulfate-d₆ (sodium dihydrate) is the deuterium labeled tert-Butyl N-[(1S)-1-[Methoxy(methyl)carbamoyl]-2-phenylethyl]carbamate[1].

HY-W719560S

Flupyrsulfuron-methyl-d6	Isotope-Labeled Compounds	Others
Flupyrsulfuron-methyl-d₆ is deuterium labeled Methyl 2-(N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)sulfamoyl)-6-(trifluoromethyl)nicotinate .

HY-145087A

NP3-146 sodium	NOD-like Receptor (NLR)	Inflammation/Immunology
NP3-146 sodium is a NLRP3 inflammasome inhibitor (WO2016131098 (N-((4-chloro-2,6-dimethylphenyl)carbamoyl)-4-(2-hydroxypropan-2- l)furan-2-sulfonamide)) .

HY-B0711R

Carglumic Acid (Standard) N-Carbamyl-L-glutamic acid (Standard)	Others	Cancer
Carglumic Acid (Standard) is the analytical standard of Carglumic Acid. This product is intended for research and analytical applications. Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.

HY-145087

NP3-146 NLRP3-IN-5	NOD-like Receptor (NLR)	Inflammation/Immunology
NLRP3-IN-5 is a NLRP3 inflammasome inhibitor (WO2016131098 (N-((4-chloro-2,6-dimethylphenyl)carbamoyl)-4-(2-hydroxypropan-2- l)furan-2-sulfonamide)) .

HY-P2331

Actagardin Antibiotic A 3802-IV-3; Gardimycin	Antibiotic	Infection
Actagardin is a tetracyclic lantibiotic produced by several species of Actinoplanes. It is composed of macrocyclic rings formed by thioether bridges. Actagardin preferably targets Gram-positive bacteria, inhibiting the synthesis of peptidoglycan.

HY-W009418S1

1-Methylnicotinamide-d4 iodide 3-carbamoyl-1-methylpyridinium iodide-d₄ iodide	Isotope-Labeled Compounds	Others
1-Methylnicotinamide-d₄ iodide is deuterated labeled 1-Methylnicotinamide.

HY-106720C

(+)-Amosulalol (+)-YM 09538	Adrenergic Receptor	Others
(+)-Amosulalol ((+)-YM 09538) is an α,β-blocker with pharmacokinetic and metabolic activities in mice. In mice, the plasma concentration of (+)-Amosulalol decreased in a biphasic manner after intravenous injection. The time to reach the maximum plasma concentration after oral administration was 0.25h, and then decreased. The systemic bioavailability was 38.7%, and it was mainly excreted through urine. Multiple metabolites were detected in urine, and a new metabolite amosulalol carbamoyl glucuronide was found in bile samples.

HY-106720B

(-)-Amosulalol (-)-YM 09538	Adrenergic Receptor	Others
(-)-Amosulalol ((-)-YM 09538) is an α,β-blocker with pharmacokinetic and metabolic activities in mice. In mice, the plasma concentration of (-)-Amosulalol decreased in a biphasic manner after intravenous injection. The time to reach the maximum plasma concentration after oral administration was 0.25h, and then decreased. The systemic bioavailability was 38.7%, and it was mainly excreted through urine. Multiple metabolites were detected in urine, and a new metabolite amosulalol carbamoyl glucuronide was found in bile samples.

HY-P1726A

MSG606 TFA	Melanocortin Receptor	Cancer
MSG606 TFA is a potent human MC1 receptor antagonist (IC₅₀=17 nM). MSG606 TFA also partial agonist at human MC3 and MC5 receptors (EC₅₀ values are 59 and 1300 nM, respectively). MSG606 TFA exhibits binding affinity for A375 melanoma cells in vitro. MSG606 TFA reverses the induced hyperalgesia in female mice, with no effect in male mice.

HY-P1726

MSG606	Melanocortin Receptor	Neurological Disease
MSG606 is a selective MC1R (melanocortin 1 receptor) antagonist and can be used for the research of neuroprotective effects .

HY-P0041

F992	Vasopressin Receptor	Neurological Disease
F992 is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .

HY-P0041A

F992 TFA	Vasopressin Receptor	Neurological Disease
F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .

HY-103027

Polyoxin B 5-(2-amino-5-O-carbamoyl-2-deoxy-L-xylonamido-1,5-dideoxy-1-(3,4-dihydro-5-hydroxymethyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-allofuranuronic acid	Fungal	Infection Inflammation/Immunology
Polyoxin B is a potent chitin synthase inhibitor (IC₅₀=0.08 mM) and an effective antifungal agent .

*3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol* DC-Chol	Drug Delivery
3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol, a lipid, has been investigated in cancer gene therapy and vaccine delivery system .

Cat. No.	Product Name	Target	Research Area

HY-79680

*(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid*	Amino Acid Derivatives	Others
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid is a phenylalanine derivative .

HY-P5126

DOTA-LM3 1 Publications Verification	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-LM3 is a somatostatin receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 is often isotopically labeled for tracing tumors in vivo, such as 177Lu-DOTA-LM3 and 68 Ga-DOTA-LM3. 68 Ga-DOTA-LM3 shows favorable biodistribution, high tumor uptake, good tumor retention, and few safety concerns. 177Lu-DOTA-LM3 can be used for research in DOTATOC-negative liver metastases, such as pancreatic NET and extensive tumor thrombosis .

HY-P5126A

DOTA-LM3 TFA 1 Publications Verification	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-LM3 TFA is a somatostatin receptor (SSTR) antagonist. LM3 refers to p-Cl-Phe- cyclo(D-Cys-Tyr-D-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr- NH2, as well as a somatostatin antagonist. DOTA-LM3 TFA is often isotopically labeled for tracing tumors in vivo, such as 177Lu-DOTA-LM3 TFA and 68 Ga-DOTA-LM3 TFA. 68 Ga-DOTA-LM3 TFA shows favorable biodistribution, high tumor uptake, good tumor retention, and few safety concerns. 177Lu-DOTA-LM3 TFA can be used for research in DOTATOC-negative liver metastases, such as pancreatic NET and extensive tumor thrombosis .

HY-P5362

NODAGA-LM3	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
NODAGA-LM3 can be labeled by ⁶⁸Ga for PET imaging. ⁶⁸Ga-NODAGA-LM3 is a SSTR2 antagonist, and can be used for imaging of SSTR positive paragangliomas .

HY-P10137

Satoreotide JR11	Somatostatin Receptor	Cancer
Satoreotide (JR11) is a SSTR2 antagonist. Satoreotide is usually conjugated with radiolabeled chelators used in neuroendocrine tumor imaing .

HY-P5128

DOTA-JR11 Satoreotide tetraxetan	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
DOTA-JR11 is a somatostatin receptor 2 （SSTR2）antagonist. DOTA-JR11 can be labeled by 68Ga, used for paired imaging in neuroendocrine tumors (NETs) research .

HY-P4756

*N-(2-Carbamoyl-ethyl)-Val-Leu-anilide*	Peptides	Others
N-(2-Carbamoyl-ethyl)-Val-Leu-anilide is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development .

HY-P5362A

NODAGA-LM3 TFA	Radionuclide-Drug Conjugates (RDCs) Somatostatin Receptor	Cancer
NODAGA-LM3 TFA can be labeled by ⁶⁸Ga for PET imaging. ⁶⁸Ga-NODAGA-LM3 TFA is a SSTR2 antagonist, and can be used for imaging of SSTR positive paragangliomas .

HY-P2331

Actagardin Antibiotic A 3802-IV-3; Gardimycin	Antibiotic	Infection
Actagardin is a tetracyclic lantibiotic produced by several species of Actinoplanes. It is composed of macrocyclic rings formed by thioether bridges. Actagardin preferably targets Gram-positive bacteria, inhibiting the synthesis of peptidoglycan.

HY-P10014

Bibapcitide	Peptides	Cardiovascular Disease
Bibapcitide, a 26 amino acid, inhibits thrombosis .

HY-P1726A

MSG606 TFA	Melanocortin Receptor	Cancer
MSG606 TFA is a potent human MC1 receptor antagonist (IC₅₀=17 nM). MSG606 TFA also partial agonist at human MC3 and MC5 receptors (EC₅₀ values are 59 and 1300 nM, respectively). MSG606 TFA exhibits binding affinity for A375 melanoma cells in vitro. MSG606 TFA reverses the induced hyperalgesia in female mice, with no effect in male mice.

HY-P0041

F992	Vasopressin Receptor	Neurological Disease
F992 is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .

HY-P0041A

F992 TFA	Vasopressin Receptor	Neurological Disease
F992 TFA is an antidiuretic peptide and vasopressin (antidiuretic hormone) analogue .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-128425A

*N-Carbamoyl-L-aspartic acid* L-Ureidosuccinic acid	Structural Classification Natural Products Classification of Application Fields Source classification Other Diseases Endogenous metabolite Disease Research Fields	Endogenous Metabolite
N-Carbamoyl-L-aspartic acid is intermediate of pyrimidine (HY-Y0519) metabolism. N-Carbamoyl-L-aspartic acid can be used to measure enzyme activity of dihydroorotase (DHOse) .

HY-128425

*N-Carbamoyl-DL-aspartic acid* Ureidosuccinic Acid	Structural Classification Human Gut Microbiota Metabolites Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Source classification Metabolic Disease Endogenous metabolite Disease Research Fields	Endogenous Metabolite
N-Carbamoyl-DL-aspartic acid (Ureidosuccinic acid) is a precursor of nucleic acid pyrimidines .

HY-B0711

Carglumic Acid 1 Publications Verification N-Carbamyl-L-glutamic acid	Human Gut Microbiota Metabolites Microorganisms Source classification Endogenous metabolite	Others
Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.

HY-B0711R

Carglumic Acid (Standard) N-Carbamyl-L-glutamic acid (Standard)	Human Gut Microbiota Metabolites Microorganisms Source classification Endogenous metabolite	Others
Carglumic Acid (Standard) is the analytical standard of Carglumic Acid. This product is intended for research and analytical applications. Carglumic acid (N-Carbamyl-L-glutamic acid), a functional analogue of N-acetylglutamate (NAG) and a carbamoyl phosphate synthetase 1 (CPS1) activator, is used to treat acute and chronic hyperammonemia associated with NAG synthase (NAGS) deficiency.

HY-103027

Polyoxin B 5-(2-amino-5-O-carbamoyl-2-deoxy-L-xylonamido-1,5-dideoxy-1-(3,4-dihydro-5-hydroxymethyl-2,4-dioxo-1(2H)-pyrimidinyl)-β-D-allofuranuronic acid	Classification of Application Fields Inflammation/Immunology Disease Research Fields	Fungal
Polyoxin B is a potent chitin synthase inhibitor (IC₅₀=0.08 mM) and an effective antifungal agent .

Cat. No.	Compare	Product Name	Species	Source

HY-P71445

	CPS1/CPSase I Protein, Human (Sf9, His) carbamoyl phosphate synthase; carbamoyl phosphate synthase mitochondrial; carbamoyl phosphate synthase; carbamoyl phosphate synthetase 1; carbamoyl phosphate synthetase 1 mitochondrial; carbamoyl phosphate synthetase I; carbamoyl-phosphate synthase [ammonia]; carbamoyl-phosphate synthetase I; carbamoylphosphate synthase; carbamoylphosphate synthetase 1; carbamoylphosphate synthetase I; CPS 1; Cps1; CPSase 1; CPSase I; CPSASE1; mitochondrial; MS738	Human	Sf9 insect cells
	The CPS1/CPSase I protein is critical in participating in the urea cycle and is essential for the elimination of excess ammonia in urea-bearing animals. This essential enzyme converts toxic ammonia (a byproduct of amino acid catabolism) into urea, promoting safe excretion. CPS1/CPSase I Protein, Human (Sf9, His) is the recombinant human-derived CPS1/CPSase I protein, expressed by Sf9 insect cells , with His labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-W009418S

1-Methylnicotinamide-13C,d3 iodide
1-Methylnicotinamide- ¹³C,d₃ (iodide) is the ¹³C- and deuterium labeled 3-Carbamoyl-1-methylpyridin-1-ium iodide[1].

HY-113416AS

Dehydroepiandrosterone sulfate-d6 sodium dihydrate
Dehydroepiandrosterone sulfate-d₆ (sodium dihydrate) is the deuterium labeled tert-Butyl N-[(1S)-1-[Methoxy(methyl)carbamoyl]-2-phenylethyl]carbamate[1].

HY-W705503

*3-Carbamoyl-1-methylpyridin-1-ium-d3 iodide*
3-Carbamoyl-1-methylpyridin-1-ium-d₃ (iodide) is deuterium-labeled 3-Carbamoyl-1-methylpyridin-1-ium .

HY-165695S

*2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-15N2*
2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)- ¹⁵N₂ is ¹⁵N labeled 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium) .

HY-146716S

*N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d3 dicyclohexylamine*
N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine-d₃ (dicyclohexylamine) is the deuterium labeled N-Acetyl-S-(N-methyl-carbamoyl)-L-cysteine.

HY-165694S

*2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)-13C2,15N2*
2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium)- ¹³C₂, ¹⁵N₂ is ¹³C and ¹⁵N labeled 2-Carbamoyl-3,5,6-trichloro-4-cyanobenzenesulfonate (sodium) .

HY-165704S

*2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium)-d4*
2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium)-d₄ is deuterium labeled 2-(3-Carbamoyl-1-((6-chloropyridin-3-yl)methyl)ureido)ethane-1-sulfonate (sodium) .

HY-W009512S1

N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d6
N-(2,6-Dimethylphenyl)-2-(piperazin-1-yl)acetamide-d₆ (N-[(2-chlorophenyl)carbamoyl]phenylalanine-d₆) is deuterium-labeled CVT-2738 (HY-W009512) .

HY-W719560S

Flupyrsulfuron-methyl-d6
Flupyrsulfuron-methyl-d₆ is deuterium labeled Methyl 2-(N-((4,6-dimethoxypyrimidin-2-yl)carbamoyl)sulfamoyl)-6-(trifluoromethyl)nicotinate .

HY-W009418S1

1-Methylnicotinamide-d4 iodide
1-Methylnicotinamide-d₄ iodide is deuterated labeled 1-Methylnicotinamide.

Cat. No.	Product Name		Classification

HY-140459

*2-((Azido-PEG8-carbamoyl)methoxy)acetic acid*		Azide PROTAC Synthesis
2-((Azido-PEG8-carbamoyl)methoxy)acetic acid is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs . 2-((Azido-PEG8-carbamoyl)methoxy)acetic acid is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.

Cat. No.	Product Name		Classification

HY-149664

*3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol* DC-Chol		Cholesterol
3β-[N-(N′,N′-Dimethylaminoethyl)carbamoyl]cholesterol, a lipid, has been investigated in cancer gene therapy and vaccine delivery system .

HY-125734

DMHAPC-Chol		Cationic Lipids
DMHAPC-Chol, a cationic lipid, contains a biodegradable carbamoyl linker and a hydroxyethyl group in the polar amino head moiety. DMHAPC-Chol can be used in both transfection experiments concerning plasmids or siRNA .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

carbamoyl

Inhibitors & Agonists

Biochemical Assay Reagents

Peptides

NaturalProducts

Recombinant Proteins

Isotope-Labeled Compounds

Click Chemistry

Oligonucleotides

Natural
Products